Healthcare AI News
News, analysis and tracking for clinical AI, medical device regulation, hospital implementation and digital health investment.
The operating model for safe healthcare AI in 2026
A board-ready framework for governing healthcare AI with clinical ownership, local validation, incident review and post-deployment monitoring.
Cardiology AI: from ECG signal to longitudinal risk intelligence
Cardiology AI has value when it links signals to defined clinical pathways, not when it produces isolated risk scores without follow-up capacity.
Pathology AI and the quiet industrialisation of diagnosis
Pathology AI is a digital-lab transformation story: algorithms matter only after slide quality, scanner consistency, routing and report integration are controlled.
Oncology AI and the economics of precision care
Oncology AI is valuable when it makes precision care usable and access-aware: molecular interpretation, trial matching and tumour-board synthesis must change real decisions.
Every Monday at 06:00 — in your inbox
ChatGPT, Claude, MedGemini, FDA AI clearances, KVKK + TITCK decisions and physician experience reports. DoktorClub editors summarize the week’s 8 most important developments with clinical implications. A trust signal for 115,000+ physician members.
- Independent editorial coverage · Sponsored items are clearly marked
- Monday 06:00 · 5-7 minute read
- One-click unsubscribe · KVKK-compliant consent flow
Deep dives on AI + healthcare
ChatGPT, Claude, MedGemini · Clinical decision support + ambient AI
FDA/CE/TITCK-cleared software · Clinical validation
AlphaFold · Generative chemistry · Clinical trial optimization
Protocol design · Digital biomarkers · Decentralized trials
Symptom triage · Digital assistants · Telemedicine
KVKK + TITCK + FDA + EU AI Act · Guidance changes
Launches · Acquisitions · IPOs · Turkey + global players
Funding rounds · VC + corporate · M&A + valuation
Latest developments
The operating model for safe healthcare AI in 2026
A board-ready framework for governing healthcare AI with clinical ownership, local validation, incident review and post-deployment monitoring.
Cardiology AI: from ECG signal to longitudinal risk intelligence
Cardiology AI is moving from isolated ECG interpretation to longitudinal cardiovascular risk pathways and remote monitoring governance.
Pathology AI and the quiet industrialisation of diagnosis
Why pathology AI depends first on digital slide infrastructure, scanner quality, reporting rules and professional trust.
Oncology AI and the economics of precision care
A practical analysis of oncology AI across molecular interpretation, trial matching, tumour boards and access-aware precision care.
AI drug discovery after AlphaFold: what changes, what does not
What AlphaFold 3 changes in biology research, and why structural prediction still must be separated from clinical drug success.
Genomics, polygenic risk and the next frontier of clinical AI
Why genomic AI needs ancestry-aware validation, counselling capacity and clinical pathways before risk scores become useful.
The data governance layer behind trustworthy medical AI
The data governance layer behind trustworthy medical AI with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Hospital procurement for healthcare AI: a playbook for executives
Hospital procurement for healthcare AI: a playbook for executives with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
The EU AI Act for physicians and hospital leaders
The EU AI Act for physicians and hospital leaders with source-led analysis, clinical governance, Turkey/regional context and a pre-publication E-E-A-T checklist.
Briefing archive
Tracker
AI-enabled medical device visibility and the FDA lifecycle approach are tracked here.
Healthcare AI readiness, governance and regional capacity signals are tracked here.
Company, integration and rollout signals across documentation and workflow automation.
"What does this mean?" files
The operating model for safe healthcare AI in 2026
A board-ready framework for governing healthcare AI with clinical ownership, local validation, incident review and post-deployment monitoring.
Cardiology AI: from ECG signal to longitudinal risk intelligence
Cardiology AI is moving from isolated ECG interpretation to longitudinal cardiovascular risk pathways and remote monitoring governance.
Pathology AI and the quiet industrialisation of diagnosis
Why pathology AI depends first on digital slide infrastructure, scanner quality, reporting rules and professional trust.
Local context boxes
Short answers about healthcare AI news
Clinical AI, medical device regulation, FDA and TITCK updates, hospital AI implementation, digital health investment and the Turkey context for healthcare AI.
Physicians, hospital leaders, digital health teams, medical device and pharma professionals, and healthcare policy readers.
Official announcements, regulatory documents, peer-reviewed publications, clinical trial records and company disclosures are separated with visible source badges.
Weekly AI Health Briefings
A weekly summary and analysis of the most important healthcare AI developments.
Open briefing archiveStart with AI Academy
AI education, research and implementation guides for healthcare professionals.
Go to Academy